Changes in Consumer Behaviour During COVID-19 Outbreak May Affect Growth of Natural Language Processing Market
What are Main Factors Expected to Cause Boom of DOA Testing Market in Asia-Pacific in Future?
Since the last few years, there has been a huge rise in the usage of illicit drugs, especially amongst the younger population all over the world. This fact is authenticated in the World Drug Report published by the United Nations Office on Drugs and Crime (UNODC) which says that almost 203 million people in the world, in the age group 15—64 years, used illicit drugs in 2013. Furthermore, the report said that the total number of people in the world using illicit drugs increased to 246 million in 2015.
Apart from revealing the total number of illicit drug users in the world in 2013 and 2015, the UNODC also reported that the consumption of cannabis amongst the high-school kids in the U.S. increased from around 24.7% to 25.8% during 2012—2013. This escalating consumption of illicit drugs has considerably increased the need for drug testing, which has, in turn, led to the development of various testing equipment such as breath analyzers and rapid test kits. Owing to these reasons, the global drug of abuse testing market will exhibit substantial growth in the forth coming years.
Geographically, the North American drug of abuse testing market recorded the highest growth over the last few years. However, the Asia-Pacific (APAC) region is predicted to generate huge demand for drug testing methods in the years to come, mainly on account of the rising consumption of illegal drugs and the increasing implementation of strict drug testing protocols in workplaces in various APAC nations. As per a report produced by the Australian Criminal Intelligence Commission (ACIC), 115,421 illegal drug seizures were made from 2015 to 2016 by the various police agencies operating in the country.
Therefore, it can be said with full surety that the sales of drug testing equipment will shoot-up across the world in the near future, primarily because of the increasing consumption of illicit drugs all over the world.
Read more: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing
How will Advancing Healthcare Sector Drive Medical Robotic Systems Market in North America?
The increasing geriatric population across the world is one of the key factors responsible for the surging usage of medical robotic systems. Moreover, the rising healthcare costs and dwindling number of healthcare providers and caregivers are significantly boosting the need for alternative caregiving methods. According to the American Association of Retired Persons (AARP), seven people in the age group 45–64 can provide care for every person aged 80 years and above, and this number will decrease massively by 2030, with only 4 people available for providing care for people aged 80 years and above.
The other major factors pushing the adoption of robotics in the medical sector are the burgeoning use of automated pharmacy systems across the world and increasing demand for medical procedures. Since the last few years, there has been a massive surge in the adoption of automated systems in the healthcare and pharmaceutical sectors, in order to streamline the work processes and optimize the services. Propelled by these factors, the global medical robotic systems market revenue is expected to increase from $7,626.1 million in 2019 to $55,528.1 million by 2030, exhibiting a CAGR of 20.1% during the forecast period (2020–2030).
The biggest trend presently being witnessed in the medical robotic systems market is the soaring number of technological developments. For instance, the California Institute of Technology (Caltech) is working on a microbot target therapy that utilizes near-microscopic mechanical particles for drug localization and administration to a certain part inside the human body, while being managed and controlled from the outside. Microbots, which consist of a coating of platelets and red blood cells and nanowires, are increasingly being deployed for destroying tumors via radiation and reducing the side-effects of medication.
Hence, it is clear that owing to the swift advancements in the healthcare sector, rising need for automated healthcare systems, and surging geriatric population, the demand for medical robotic systems will boom in the coming years.
Read more: https://www.psmarketresearch.com/market-analysis/medical-robotic-systems-market
What are Major Factors Contributing to Boom of Carrier Screening Market in Asia-Pacific?
The rising incidence of genetic diseases is one of the biggest factors responsible for the surge in the adoption of carrier screening processes across the world. The risk and severity of most of the genetic diseases depend on the patient’s ancestors and carrier status. The American College of Obstetricians and Gynecologists recommends the testing of all pregnant women and those considering motherhood in future in order to detect early the risk of various diseases such as fragile X syndrome, spinal muscular atrophy (SMA), and cystic fibrosis.
Due to the above-mentioned factors, the global carrier screening market attained a valuation of $1,303.6 million in 2019 and is expected to exhibit a CAGR of 10.9% during the forecast period (2020–2030). There are mainly two types of carrier screening methods used for detecting genetic diseases — expanded carrier screening and targeted carrier screening. Of these, the expanded carrier screening method recorded higher utilization in 2019. This is ascribed to the fact that this method of carrier screening makes it possible to test for multiple diseases at the same time.
To learn more about this report: https://bit.ly/2N2Eud3 |
One of the major trends currently being witnessed in the carrier screening market is the increasing acquisition of smaller organizations providing solutions for carrier screening tests by the larger biotechnology companies. For instance, Quest Diagnostics Inc. announced its acquisition of a specialist genetic testing solutions company called Blueprint Genetics in January 2020, in order to attain expertise in pharmaceutical drug research and development (R&D), rare genetic diseases, and in the various methods of improving patient care.
Globally the Asia-Pacific (APAC) region is expected to observe the fastest growth in the utilization of carrier screening methods during the forecast period. This is mainly credited to the soaring awareness amongst the masses about genetic screening tests in China, Australia, and India and the rising concerns amongst the people about the health and well-being of their future children. In addition to this, the high occurrence rate of genetic diseases in the various densely populated countries of APAC such as China and India will further propel the demand for carrier screening procedures in the region in future.
Report Coverage
·
Provides
comprehensive understanding of the market with the help of informed market outlook,
opportunities, challenges, trends, size and growth, competitive analysis, major
competitors and Porter analysis
·
Identifies the
key drivers of growth and challenges of the key industry players. Also,
assesses the future impact of the propellants and restraints on the market
·
Uncovers
potential demands in the market
· Porter analysis identifies competitive forces within the market
Global Gene Therapy Market to Register 31.1% CAGR during 2020-2030
The burden of chronic diseases has only been increasing since past few years. The cases for cancer, for example, are growing rapidly. According to the American Cancer Society, from 2016–2019, the number of new cases of cancer in the U.S. increased from 1,685,210 to 1,762,450, and the cancer mortality rose from 595,690 to 606,880 during the same time period. Doubtless, a number of advancements have been made in the medical industry for developing a proper cure for cancer and other rare chronic diseases, however, the fact remains that there is a long way to go before anything certain comes to light.
The advancements regarding gene therapy though can significantly aid in getting closer to dealing properly with several chronic diseases. Gene therapy is designed for introducing genetic material into cells for compensating for abnormal genes or for making a beneficial protein. In case a mutated gene causes an essential protein to be faulty or non-existent, gene therapy may potentially be able to introducing a new copy of the gene for restoring the function of the protein. Attributed to these reasons, the gene therapy market generated revenue of $3,407.5 million in 2019 and is expected to advance at a 31.1% CAGR during the forecast period (2020–2030).
In 2019, North America was the largest gene therapy market, which is ascribed to the rising number of cancer and rare disease cases and the presence of a large number of key companies in the region. In addition to this, various gene therapy products are getting regulatory approvals in North America. Other than this, the adoption of gene therapy is also projected to rise substantially in the Asia-Pacific because of the cost-effective labor and rising activities of major industry players.
Browse full report at: https://www.psmarketresearch.com/market-analysis/gene-therapy-market
This Study Covers
mPOS Terminals Market | Covid19 Impact Analysis | Business Outlook, Growth, Revenue, Trends and Forecasts 2030
Used Car Market Status & Supply Demand | Industry Forecast Report To 2030
Based on sector, the used car market is divided into unorganized and organized categories. Between the two, the organized division is predicted to exhibit faster growth in the coming years. This is credited to the higher preference of customers for dealer certified vehicles as compared to the vehicles sold in the unorganized sector without any guarantees and warrantees. Due to this factor, the certified programs are becoming a critical differentiating factor for the organized sector players. In addition to this, the rising popularity of online portals for both buying and selling of used vehicles in the developed nations such as the U.K., the U.S., Japan, and Germany will further boost the progress of the organized sector division in the market in the future years.